Researchers from the University of Tübingen and the DZIF show medicine is effective when the timing is right. Their new active substance – DSM 265 – demonstrated a good prophylactic effect for Malaria
During pregnancy, a mother’s immune system is suppressed to protect the fetus, which is perceived as a foreign body because it is genetically different. A partly DZIF funded study in mice found that
This year, the Memento Research Award for neglected diseases goes to Dr Carsten Köhler and Prof Peter Kremsner from the Institute of Tropical Diseases at the University Hospital Tübingen. With this
The human immunodeficiency virus has to overcome major obstacles to infect inactive immune cells. DZIF scientists have investigated the defence mechanism of these cells and found indications of a new
Since autumn 2015, the Zika virus epidemic has been causing marked increases in the birth of babies with much too small heads, or so-called “microcephaly”, especially in South and Central America. The
Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ
Almost everybody has it: Scientists estimate that approximately 98 percent of adults around the world are infected with the Epstein-Barr virus. In rare cases, an infection with this virus causes
Severe malaria, caused by the Plasmodium falciparum parasite, causes dangerous circulatory disorders and neurological complications. If the affected person is not treated immediately, the disease will
Colistin is used as the “last-resort antibiotic” for dreaded multidrug-resistant pathogens, especially in hospitals. However, gut bacteria that have become insensitive to colistin now exist—owing to
An international team of scientists has sequenced the genomes of two rare malaria pathogens, both parasites of the plasmodium species. A scientist from the Bernhard Nocht Institute for Tropical
